Skip to main content
Clinical Trials/NCT06514729
NCT06514729RecruitingNot Applicable

The Effects of Different Ventilation Modes on Patients With Plasma Inflammatory Factor and Respiratory Function in Patients With Pulmonary Lobe Resection

Mao Enting1 site in 1 country102 target enrollmentStarted: January 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
102
Locations
1
Primary Endpoint
Clinical Pulmonary Infection Score

Study Overview

Brief Summary

The objective of this study was to discuss the effects of different ventilation modes on patients with plasma inflammatory factor and respiratory function in patients with pulmonary removal.

Detailed Description

Patients who meet the inclusion criteria will be numbered in the order of admission, and a dedicated person will prepare codes and opaque envelopes for random allocation. This study was divided into 3 groups, one groups was ventilation side volume control ventilation+continuous positive pressure ventilation on the non ventilation side, the other groups was ventilation side volume control ventilation+continuous positive pressure ventilation on the non ventilation side; the other groups was ventilation side pressure regulated volume control ventilation+continuous positive pressure ventilation on the non ventilation side.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Other
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

The researchers in this study enrolled suitable patients using a random number table method before surgery, and then performed different intraoperative single lung ventilation modes according to the grouping after unblinding the patients upon entering the room. The postoperative follow-up personnel or data analysts are unaware of the grouping status.

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Comprehensive examination and analysis of imaging, laboratory examination and other comprehensive examinations, the diagnosis is clear, which is in line with lobe resection surgical indications
  • Age 18-75 years old, the gender is not limited;
  • ASA grading Ⅰ ~ III level;
  • It is expected that the single lung ventilation time is ≥1 hours, and ≤3 hours

Exclusion Criteria

  • Emergency surgery;
  • There is a taboos on the existence of systemic anesthesia;
  • There is a history of acute chronic upper respiratory infections in the past January;
  • Previous bronchial asthma, chronic obstructive pulmonary disease, bronchial dilatation, phthisis ,aspergillosis , acute respiratory distress syndrome or history of respiratory failure;
  • Merge the function of important organs such as heart, liver, and kidney;
  • There was a history of chest surgery and the history of trauma;
  • Preoperative lung function test obvious abnormal abnormal abnormalities (1 second of exhalation (FEV1) <60%);
  • Patients refuse to participate in the clinical trial

Outcomes

Primary Outcomes

Clinical Pulmonary Infection Score

Time Frame: Within 15 days after surgery

The clinical pulmonary infection score index is mainly used to evaluate the severity of pulmonary infection, which involves many factors, including: body temperature, white blood cell count, tracheal secretions, oxygenation, X-ray chest X-ray, and the progress of pulmonary infiltrates. The maximum score is 12 points, and the severity of infection is directly proportional to its score.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Mao Enting
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Mao Enting

Anesthesiology resident,Affiliate Hospital of Zunyi Medical University

Zunyi Medical College

Study Sites (1)

Loading locations...

Similar Trials